Skip to main content

BIPS presents project for improved detection of metabolic syndrome in children

The Biomarkers4Pediatrics project aims to enable early interventions for the prevention and treatment of the metabolic syndrome in children. Dr. Timm Intemann presented the initiative at the World Congress of Epidemiology 2024 in Cape Town. Currently, 14 studies from 22 countries are involved, and the network is set to expand.

Promoting international collaboration: Dr. Timm Intemann at the World Congress of Epidemiology 2024 in Cape Town. (c) BIPS/Intemann

Biomarkers4Pediatrics: An international network
Metabolic syndrome, which includes conditions such as obesity, high blood sugar levels, and lipid metabolism disorders, is often diagnosed late in children. To address this, a comprehensive data foundation is needed for assessing the syndrome that takes into account the age, gender, and origin of the children. The Biomarkers4Pediatrics project is gathering global data from various research initiatives and creates reference curves for biological markers. These serve as valuable guidelines for paediatricians to identify the condition early, thereby improving prevention, diagnosis, and treatment. Currently, 14 studies from 22 countries are part of the network.

World Congress in Cape Town: Exchange on a global level
The World Congress of Epidemiology brings together leading experts in the field of epidemiology to discuss current challenges in researching and combating diseases at a population level. Dr. Timm Intemann, operational project lead at the interdisciplinary Centre for Research Data Infrastructure and Data Science at BIPS, presented the goals of Biomarkers4Pediatrics at the 2024 annual meeting and engaged with potential new collaborators. He emphasised the knowledge gained from networking studies and linking different data, particularly regarding children's growth and blood pressure, both in Africa and globally.
-----------

More information about the Biomarkers4Pediatrics project can be found here.